Jin Li

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>

Shu Tian, Haitian Quan, Chengying Xie et al. · Cancer Science · 2011 · 516 citations · Full text

Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer

Jin Li, Shukui Qin, Rui‐Hua Xu et al. · JAMA · 2018 · 378 citations · Full text

Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer

Xichun Hu, Jun Cao, Wenwei Hu et al. · BMC Cancer · 2014 · 233 citations · Full text

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

Xinru Wei, Yunxin Lai, Jin Li et al. · OncoImmunology · 2017 · 132 citations · Full text

MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer

Xiaoxiao Ge, Xinyang Liu, Fengjuan Lin et al. · Oncotarget · 2016 · 117 citations · Full text

Pathology, Cell Death, Gastric Cancer Specimens +16